NCT03493243已完成不适用
AVAL Cohort Study First Step, Observational Study, After One Year
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 40
- 试验地点
- 2
- 主要终点
- PTSD
研究概览
简要总结
- Context: Since March 2012, several terrorist attacks have been perpetrated in France (Toulouse, Montauban, Paris, Nice ...). In March 2017, 53 french teenagers were victims in a terrorist attack in London (Westminster Bridge).
- Main goal = to estimate the psycho-traumatic impact and to describe cares and management of high school students, victims of the terrorist attack in London on 2017, March the 22nd.
- 3 secondary objectives: 1) Clinical (occurrence of Post Traumatic Stress Disorders or other disorders); 2) Epidemiological (risk factors for developing disorders, avoiding care); 3) Preventive and therapeutic.
详细描述
Inclusion criterion: 53 teenagers of Saint-Joseph high school (Concarneau, France) directly exposed to the terrorist attack.
Methodology: self questionnaires and heterogenous questionnaires; descriptive statistics (means +/- standard deviations; search for a significant difference according to traumatic symptomatology)
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 14 Years 至 20 Years（Child, Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •53 teenagers, from Concarneau (France) high school, directly exposed from London terrorist attack (22.03.2017).
排除标准
- •All persons not directly exposed;
- •Relatives of teenagers;
- •3 physically injured teenagers.
结局指标
主要结局
PTSD
时间窗: One year after the terrorist attack (Day 1)
Post Traumatic Stress Disorder (Self-Questionnaire :Posttraumatic stress disorder checklist 5 )
次要结局
- Preventive and therapeutic(One year after the terrorist attack (Day 1))
- Clinical (occurence of Post Traumatic Stress Disorders or other disorders)(One year after the terrorist attack (Day 1))
- Epidemiological (risk factors for developing disorders, avoiding care);(One year after the terrorist attack (Day 1))
研究者
COULON Nathalie
medical doctor (psychiatrist for children and teenagers), principal Investigator
University Hospital, Brest
研究点 (2)
Loading locations...
相似试验
已完成
不适用
*A Two Part Phase I Study to Assess Safety, Tolerability, Systemic Exposure and Effect on Analgesia and Anaesthesia of Single and Multiple doses of TDT 077 in Healthy Older Subjects.*Neuropathic pain10034606NL-OMON31518Celtic Pharma Development Services Europe Ltd.96
进行中（未招募）
1 期
A Phase 1/2 Study to Evaluate the Safety, Tolerability, and Efficacy of VX-880 in Subjects Who Have Type 1 Diabetes Mellitus With Impaired Hypoglycemic Awareness and Severe HypoglycemiaType 1 Diabetes Mellitus with Impaired Hypoglycemic Awareness and Severe HypoglycemiaMedDRA version: 20.0Level: PTClassification code 10012601Term: Diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersMedDRA version: 21.1Level: LLTClassification code 10081605Term: Severe hypoglycemiaSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2022-002292-11-DEVertex Pharmaceuticals Incorporated37
招募中
2 期
A Safety, Tolerability, and Efficacy Study of VX-264 in Subjects With Type 1 DiabetesType 1 Diabetes Mellitus2024-515583-32-00Vertex Pharmaceuticals Inc., Vertex Pharmaceuticals Inc.4
招募中
3 期
A Phase 1/2/3 Study to Evaluate the Safety, Tolerability, and Efficacy of VX- 880 in Subjects Who Have Type 1 Diabetes Mellitus With Impaired Hypoglycemic Awareness and Severe Hypoglycemia2024-513929-23-00Vertex Pharmaceuticals Inc.16
进行中（未招募）
1 期
A clinical study to evaluate the safety, tolerability, and efficacy of INCB001158 in combination with chemotherapy in subjects with advanced or metastatic solid tumors.EUCTR2017-002904-29-GBIncyte Corporation249